Does MRI-TRUS fusion increase the detection rate of prostate cancer in primary biopsy setting in patients with PSA ≤ 20ng/ml?
Minárik, I., Koldová, M., Babjuk, M.Volume:
16
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(17)32022-5
Date:
November, 2017
File:
PDF, 71 KB
english, 2017